v3.25.3

Unaudited Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income - EUR (€)
€ in Thousands

3 Months Ended

9 Months Ended

Sep. 30, 2025

Sep. 30, 2024

Sep. 30, 2025

Sep. 30, 2024

Unaudited Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income

Revenue

€ 2,882

€ 3,843

€ 11,218

€ 14,598

Other income

138

413

504

Research and development costs

(11,080)

(9,414)

(34,811)

(25,745)

General and administrative costs

(3,119)

(3,283)

(11,169)

(9,748)

Total operating costs

(14,199)

(12,697)

(45,980)

(35,493)

Operating result

(11,284)

(8,716)

(34,349)

(20,391)

Finance income and expense

280

469

927

1,470

(2)

139

176

266

Result before corporate income taxes

(11,006)

(8,108)

(33,246)

(18,655)

Income taxes

(18)

197

Result for the period

(11,006)

(8,108)

(33,264)

(18,458)

Other comprehensive income (foreign exchange differences on foreign operation)

(23)

(377)

(1,076)

(101)

Total comprehensive income

(11,029)

(8,485)

(34,340)

(18,559)

Result attributable to

Owners of the Company

(11,006)

(8,108)

(33,264)

(18,458)

Result for the period

(11,006)

(8,108)

(33,264)

(18,458)

Total comprehensive income attributable to

Owners of the Company

(11,029)

(8,485)

(34,340)

(18,559)

Total comprehensive income

€ (11,029)

€ (8,485)

€ (34,340)

€ (18,559)

Share information

Weighted average number of shares outstanding (basic)

^[1]

105,344,996

81,682,296

105,328,752

81,639,533

Weighted average number of shares outstanding (diluted)

105,344,996

81,682,296

105,328,752

81,639,533

Earnings per share attributable to owners of the Company (Euro per share)

Basic loss per share

^[1]

€ (0.1)

€ (0.32)

€ (0.23)

Diluted loss per share

^[1]

€ (0.1)

€ (0.32)

€ (0.23)

[1]	For these periods the potential exercise of share options is not included in the diluted earnings per share as the Company was loss-making. Due to the anti-dilutive nature of the outstanding options, basic and diluted earnings per share are equal.

- Definition

The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2025-01-01
-Paragraph 70
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_b&doctype=Standard
-URIDate 2025-03-27

ProQR Therapeutics N.V. 6-K